TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.8271$ -2.3% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Cash Flow

Canopy Growth Corp (CGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -25 million CAD. Tick rows to compare them in a chart.

All figures in millions of CAD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CGC
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-5.2 -2.4 -16 -12 -10 -22 -37 -68 -130 -97 -226 -158 -214 -190 -224 -119 -162 -88 -98 -166 -86 -167 -127 -141 -133 -144 -140 -149 -79 -33 -22 -52 -54 -27 -33 -10 -18 -17 -18 -25 -78
1.0 1.0 3.1 5.1 5.3 5.2 5.0 6.3 9.4 7.9 23 21 25 30 40 34 32 32 29 25 29 30 30 22 20 19 21 17 13 12 11 11 10 10 11 9.7 9.2 8.9 8.7 10 37
1.3 2.1 5.7 4.0 7.3 19 21 31 100 64 93 87 93 62 78 31 22 20 19 13 16 6.8 12 5.4 9.4 6.1 9.5 3.7 2.7 3.7 4.1 4.2 5.2 5.2 -19 -0.1 2.0 0.9 1.5 1.4 5.7
0.0 0.0 -7.0 -5.1 -4.9 -13 20 22 247 -20 236 1,170 203 6.1 -587 36 -202 798 524 61 -794 -30 261 3,903 77 104 -84 -84 – – – – – – – – – – – – –
-5.6 3.5 -6.4 -7.7 -4.9 -14 -5.8 -38 -50 -41 -133 -74 -107 -73 30 -5.5 -35 33 49 -42 94 -44 157 -22 12 1.5 94 -36 5.4 8.0 26 -12 -23 2.0 1.8 8.3 -1.6 -1.2 15 -6.6 5.8
5.0 8.0 13 9.8 16 61 91 156 143 236 147 220 230 175 103 65 33 47 29 21 17 2.8 6.9 2.9 2.3 2.2 3.1 2.3 1.2 0.5 0.1 3.9 2.6 1.6 3.1 1.5 1.5 1.9 1.1 0.7 5.2
-5.0 -8.7 -1.2 -10 -24 -96 -93 -183 -193 -1,409 -1,443 -406 -530 654 -66 -426 -142 239 -555 -375 328 -25 302 121 86 135 91 143 60 -0.6 39 -33 1.0 -15 -1.0 -0.7 17 5.3 -43 -0.7 -21
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 103 1.2 22 199 13 0.0 0.0 810 5,294 17 37 41 43 250 256 – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 2.1 -0.3 -0.3 -0.3 -0.3 455 -0.4 -0.9 1.5 -98 -0.8 -13 12 -1.9 -2.5 -8.9 891 -48 -1.9 -0.2 -0.5 -0.4 -0.2 -118 -118 -118 – – – – -1.6 -135 -141 -0.9 -71 0.0 58 0.0 -13
36 58 26 36 27 248 215 586 95 5,089 67 -82 19 -8.8 28 247 3.5 18 996 -45 -1.7 0.3 0.8 -1.0 -11 -134 126 -133 -274 -66 8.5 106 89 -30 -16 25 169 91 47 -7.5 299
26 47 9.3 14 -7.3 129 85 335 -228 3,686 -1,635 -664 -714 459 -258 -327 -303 152 330 -595 248 -192 161 -6.5 -23 -149 79 -144 -290 -100 28 22 36 -67 -48 12 172 73 -6.6 -28 210
-10 -10 -29 -22 -27 -83 -128 -224 -274 -333 -373 -378 -444 -365 -328 -183 -195 -135 -127 -187 -103 -170 -134 -143 -136 -146 -143 -151 -80 -33 -22 -56 -56 -29 -36 -12 -19 -19 -19 -26 -84

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?